Llwytho...
Safety of biologics in inflammatory bowel disease patients with COVID-19
BACKGROUND: Patients with Inflammatory bowel disease (IBD) remain highly concerned that either their disease or medications—namely, biologics—may increase the risk of severe coronavirus-2019 (COVID-19). We aimed to assess the safety of biologics in Inflammatory bowel disease (IBD) patients with COVI...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Int J Colorectal Dis |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Springer Berlin Heidelberg
2021
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8205311/ https://ncbi.nlm.nih.gov/pubmed/34131784 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00384-021-03977-9 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|